Brendan L. Flannery, PhD - Publications

Affiliations: 
Center Disease Control, Atlanta, GA, United States 
Area:
http://www.biomedexperts.com/Profile.bme/405697/Brendan_Flannery
Website:
http://www.hibaction.org/hibinitiative/flannery_b.php

131 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Tenforde MW, Weber ZA, Yang DH, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Gaglani M, Fireman B, Lewis N, Zerbo O, Goddard K, Timbol J, Hansen JR, Grisel N, ... ... Flannery B, et al. Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. The Journal of Infectious Diseases. 230: 141-151. PMID 39052725 DOI: 10.1093/infdis/jiad542  0.392
2024 Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, ... ... Flannery B, et al. Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of Infectious Diseases. 230: 45-54. PMID 39052724 DOI: 10.1093/infdis/jiae090  0.635
2024 Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, ... Flannery B, et al. Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and Other Respiratory Viruses. 18: e13339. PMID 39012045 DOI: 10.1111/irv.13339  0.568
2024 Boyce TG, Levine MZ, McClure DL, King JP, Flannery B, Nguyen HQ, Belongia EA. Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human Vaccines & Immunotherapeutics. 20: 2370087. PMID 38982712 DOI: 10.1080/21645515.2024.2370087  0.394
2024 Chung JR, Shirk P, Gaglani M, Mutnal MB, Nowalk MP, Moehling Geffel K, House SL, Curley T, Wernli KJ, Kiniry EL, Martin ET, Vaughn IA, Murugan V, Lim ES, Saade E, ... ... Flannery B, et al. Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023. Influenza and Other Respiratory Viruses. 18: e13342. PMID 38923314 DOI: 10.1111/irv.13342  0.38
2024 Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S. Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of Infectious Diseases. PMID 38687898 DOI: 10.1093/infdis/jiae220  0.406
2024 King JP, Chung JR, Donahue JG, Martin ET, Leis AM, Monto AS, Gaglani M, Dunnigan K, Raiyani C, Saydah S, Flannery B, Belongia EA. Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period. Bmc Infectious Diseases. 24: 300. PMID 38454352 DOI: 10.1186/s12879-024-09108-3  0.312
2024 Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, ... ... Flannery B, et al. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. Mmwr. Morbidity and Mortality Weekly Report. 73: 168-174. PMID 38421935 DOI: 10.15585/mmwr.mm7308a3  0.639
2024 Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, ... ... Flannery B, et al. Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. Nature Communications. 15: 254. PMID 38177116 DOI: 10.1038/s41467-023-44551-x  0.413
2023 Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, ... Flannery B, et al. Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 38014151 DOI: 10.1101/2023.11.17.23298700  0.575
2023 Tenforde MW, Dawood FS, Ellington SR, Grohskopf LA, Flannery B, Garg S, Reed C. Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance. Annals of Internal Medicine. PMID 38011706 DOI: 10.7326/M23-2802  0.348
2023 Adams K, Weber ZA, Yang DH, Klein NP, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Rao S, Gaglani M, Flannery B, Garg S, Kharbanda AB, Grannis SJ, Ong TC, et al. Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, VISION Network. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37972288 DOI: 10.1093/cid/ciad704  0.398
2023 Ahmed F, Nowalk MP, Zimmerman RK, Bear T, Grijalva CG, Talbot HK, Florea A, Tartof SY, Gaglani M, Smith M, McLean HQ, King JP, Martin ET, Monto AS, Phillips CH, ... ... Flannery B, et al. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. Emerging Infectious Diseases. 29. PMID 37917142 DOI: 10.3201/eid2912.231070  0.579
2023 Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Chung JR, Rogier E, Coughlin MM, ... Flannery B, et al. Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 37790578 DOI: 10.1101/2023.09.21.23295919  0.588
2023 Schmader KE, Liu CK, Flannery B, Rountree W, Auerbach H, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Harrington T, Li R, Broder KR, Walter EB. Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immunity & Ageing : I & A. 20: 30. PMID 37393237 DOI: 10.1186/s12979-023-00355-7  0.37
2023 Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, et al. Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020. Open Forum Infectious Diseases. 10: ofad223. PMID 37305842 DOI: 10.1093/ofid/ofad223  0.382
2023 Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B. Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and Other Respiratory Viruses. 17: e13143. PMID 37246146 DOI: 10.1111/irv.13143  0.632
2023 Williams KV, Li ZN, Zhai B, Alcorn JF, Nowalk MP, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Merranko AJ, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial to compare immunogenicity to cell-based vs. live-attenuated influenza vaccines in children. Journal of the Pediatric Infectious Diseases Society. PMID 37232430 DOI: 10.1093/jpids/piad033  0.378
2023 Kniss K, Sumner KM, Tastad KJ, Lewis NM, Jansen L, Julian D, Reh M, Carlson E, Williams R, Koirala S, Buss B, Donahue M, Palm J, Kollmann L, Holzbauer S, ... ... Flannery B, et al. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022. Emerging Infectious Diseases. 29. PMID 37095080 DOI: 10.3201/eid2906.230103  0.307
2023 Bi Q, Dickerman BA, McLean HQ, Martin ET, Gaglani M, Wernli KJ, Goundappa B, Flannery B, Lipsitch M, Cobey S. Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning. Medrxiv : the Preprint Server For Health Sciences. PMID 37016669 DOI: 10.1101/2023.03.12.23287173  0.408
2023 Hood N, Flannery B, Gaglani M, Beeram M, Wernli K, Jackson ML, Martin ET, Monto AS, Zimmerman R, Raviotta J, Belongia EA, McLean HQ, Kim S, Patel MM, Chung JR. Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. PMID 36960655 DOI: 10.1542/peds.2022-059922  0.389
2023 Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B, Chung JR. Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. Medrxiv : the Preprint Server For Health Sciences. PMID 36711929 DOI: 10.1101/2023.01.10.23284397  0.632
2023 Tenforde MW, Weber ZA, DeSilva MB, Stenehjem E, Yang DH, Fireman B, Gaglani M, Kojima N, Irving SA, Rao S, Grannis SJ, Naleway AL, Kirshner L, Kharbanda AB, Dascomb K, ... ... Flannery B, et al. Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network. The Journal of Infectious Diseases. PMID 36683410 DOI: 10.1093/infdis/jiad015  0.375
2023 Thomas CM, White EB, Kojima N, Fill MA, Hanna S, Jones TF, Newhouse CN, Orejuela K, Roth E, Winders S, Chandler DR, Grijalva CG, Schaffner W, Schmitz JE, DaSilva J, ... ... Flannery B, et al. Early and Increased Influenza Activity Among Children - Tennessee, 2022-23 Influenza Season. Mmwr. Morbidity and Mortality Weekly Report. 72: 49-54. PMID 36656786 DOI: 10.15585/mmwr.mm7203a1  0.382
2022 Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, ... ... Flannery B, et al. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and Other Respiratory Viruses. 16: 975-985. PMID 36825251 DOI: 10.1111/irv.13029  0.57
2022 Williams KV, Moehling Geffel K, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Susick M, Zimmerman RK. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine. Vaccine. PMID 36543682 DOI: 10.1016/j.vaccine.2022.12.041  0.347
2022 Price AM, Flannery B, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Mutnal M, Geffel KM, Nowalk MP, Tartof SY, et al. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36504336 DOI: 10.1093/cid/ciac941  0.62
2022 Jackson ML, Phillips CH, Wellwood S, Kiniry E, Jackson LA, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Dunnigan K, Raiyani C, Murthy K, Flannery B, Chung JR. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. Vaccine. PMID 36379754 DOI: 10.1016/j.vaccine.2022.11.011  0.412
2022 Gaglani M, Kim SS, Naleway AL, Levine MZ, Edwards L, Murthy K, Dunnigan K, Zunie T, Groom H, Ball S, Jeddy Z, Hunt D, Wesley MG, Sambhara S, Gangappa S, ... ... Flannery B, et al. Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36031405 DOI: 10.1093/cid/ciac683  0.372
2022 Chung JR, Kim SS, Flannery B, Smith ME, Dunnigan K, Raiyani C, Murthy K, Gaglani M, Jackson ML, Jackson LA, Bear T, Moehling Geffel K, Nowalk MP, Zimmerman RK, Martin ET, et al. Vaccine-associated attenuation of subjective severity among outpatients with influenza. Vaccine. PMID 35710506 DOI: 10.1016/j.vaccine.2022.06.019  0.397
2022 Li ZN, Liu F, Jefferson S, Horner L, Carney P, Johnson MDL, King JP, Martin ET, Zimmerman RK, Wernli K, Gaglani M, Thompson M, Flannery B, Stevens J, Tumpey T, et al. Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35684961 DOI: 10.1093/cid/ciac472  0.451
2022 Regan AK, Wesley MG, Gaglani M, Kim SS, Edwards LJ, Murthy K, Jeddy Z, Naleway AL, Flannery B, Dawood FS, Groom H. Consistency of self-reported and documented historical influenza vaccination status of US healthcare workers. Influenza and Other Respiratory Viruses. PMID 35415884 DOI: 10.1111/irv.12988  0.376
2022 Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, ... ... Flannery B, et al. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 365-370. PMID 35271561 DOI: 10.15585/mmwr.mm7110a1  0.631
2022 Williams KV, Zhai B, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Jaber Merranko A, Nagg JP, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine. 40: 780-788. PMID 34952751 DOI: 10.1016/j.vaccine.2021.12.034  0.377
2021 Delahoy MJ, Mortenson L, Bauman L, Marquez J, Bagdasarian N, Coyle J, Sumner K, Lewis NM, Lauring AS, Flannery B, Patel MM, Martin ET. Influenza A(H3N2) Outbreak on a University Campus - Michigan, October-November 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1712-1714. PMID 34882659 DOI: 10.15585/mmwr.mm7049e1  0.345
2021 Spencer S, Chung JR, Belongia EA, Sundaram M, Meece J, Coleman LA, Zimmerman RK, Nowalk MP, Moehling Geffel K, Ross T, Carter CE, Shay D, Levine M, Liepkalns J, Kim JH, ... ... Flannery B, et al. Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. Influenza and Other Respiratory Viruses. PMID 34859584 DOI: 10.1111/irv.12933  0.369
2021 McLean HQ, Levine MZ, King JP, Flannery B, Belongia EA. Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years. Vaccine. PMID 34774360 DOI: 10.1016/j.vaccine.2021.10.072  0.356
2021 Kim SS, Chung JR, Belongia EA, McLean HQ, King JP, Nowalk MP, Zimmerman RK, Balasubramani GK, Martin ET, Monto AS, Lamerato LE, Gaglani M, Smith ME, Dunnigan KM, Jackson ML, ... ... Flannery B, et al. mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021. The Journal of Infectious Diseases. PMID 34498052 DOI: 10.1093/infdis/jiab451  0.37
2021 Griggs EP, Flannery B, Foppa IM, Gaglani M, Murthy K, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Martin ET, Monto AS, Zimmerman RK, Balasubramani GK, Chung JR, Patel M, et al. Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network. American Journal of Epidemiology. PMID 34274963 DOI: 10.1093/aje/kwab205  0.367
2021 Dawood FS, Naleway AL, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards L, Ball S, Beacham L, Belongia E, Bounds K, Cao W, Gross FL, Groom H, et al. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34245243 DOI: 10.1093/cid/ciab566  0.352
2021 Chung JR, Flannery B, Kim SS, Gaglani M, Raiyani C, Belongia EA, McLean HQ, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Martin ET, Monto AS, Patel M. Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. Vaccine. PMID 33994240 DOI: 10.1016/j.vaccine.2021.05.004  0.374
2021 Jackson ML, Ferdinands J, Nowalk MP, Zimmerman RK, Kieke B, Gaglani M, Murthy K, Petrie JG, Martin ET, Chung JR, Flannery B, Jackson LA. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. Bmc Public Health. 21: 516. PMID 33726743 DOI: 10.1186/s12889-021-10543-z  0.384
2021 Wu MJ, Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Gaglani M, Reis M, Beeram M, Martin ET, Monto AS, Nowalk MP, Zimmerman R, Santibanez TA, ... ... Flannery B, et al. Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. Vaccine. PMID 33597114 DOI: 10.1016/j.vaccine.2021.01.065  0.402
2021 Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, King JP, Zimmerman RK, Nowalk MP, Martin ET, Monto AS, Gaglani M, Smith ME, Patel M, Flannery B. Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infectious Diseases. 8: ofaa576. PMID 33537361 DOI: 10.1093/ofid/ofaa576  0.331
2020 Tenforde MW, Kondor RJG, Chung JR, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Rao A, Kim SS, Stark TJ, ... ... Flannery B, et al. Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33367650 DOI: 10.1093/cid/ciaa1884  0.399
2020 Hinojosa M, Shepard SS, Chung JR, King JP, McLean HQ, Flannery B, Belongia EA, Levine MZ. Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children. The Journal of Infectious Diseases. PMID 33090202 DOI: 10.1093/infdis/jiaa665  0.435
2020 Balasubramani GK, Choi WS, Nowalk MP, Zimmerman RK, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Jackson ML, Jackson LA, Chung JR, Spencer S, Fry AM, ... ... Flannery B, et al. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. Vaccine. PMID 32800465 DOI: 10.1016/J.Vaccine.2020.08.011  0.38
2020 Flannery B, Meece JK, Williams JV, Martin ET, Gaglani M, Jackson ML, Talbot HK. Systematic testing for influenza and COVID-19 among patients with respiratory illness. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32687197 DOI: 10.1093/Cid/Ciaa1023  0.335
2020 Moehling KK, Zimmerman RK, Nowalk MP, Jeng Lin C, Martin JM, Alcorn JF, Susick M, Burroughs A, Holiday C, Flannery B, Levine MZ. A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children. Vaccine. PMID 32580919 DOI: 10.1016/j.vaccine.2020.06.023  0.352
2020 Kim SS, Flannery B, Foppa IM, Chung JR, Nowalk MP, Zimmerman RK, Gaglani M, Monto AS, Martin ET, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Patel M. Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32505128 DOI: 10.1093/Cid/Ciaa706  0.328
2020 Chung JR, Flannery B, Gaglani M, Smith ME, Reis EC, Hickey RW, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Martin ET, Segaloff HE, Kim SS, Patel MM. Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness. Jama Pediatrics. PMID 32364599 DOI: 10.1001/jamapediatrics.2020.0372  0.398
2020 Patel M, Chen J, Kim S, Garg S, Flannery B, Haddadin Z, Rankin D, Halasa N, Talbot HK, Reed C. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States. Emerging Infectious Diseases. 26. PMID 32348234 DOI: 10.3201/eid2608.191493  0.339
2020 Smith ER, Fry AM, Hicks LA, Fleming-Dutra KE, Flannery B, Ferdinands J, Rolfes MA, Martin ET, Monto AS, Zimmerman RK, Nowalk MP, Jackson ML, McLean HQ, Olson SC, Gaglani M, et al. Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32322875 DOI: 10.1093/Cid/Ciaa464  0.338
2020 Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR, Martin ET, Monto AS, Jackson ML, Gaglani MJ, Flannery B, Chung JR, Zimmerman RK. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Influenza and Other Respiratory Viruses. PMID 32298048 DOI: 10.1111/Irv.12741  0.392
2020 Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, ... ... Flannery B, et al. Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32270198 DOI: 10.1093/Cid/Ciaa407  0.402
2020 Belongia EA, Levine MZ, Olaiya O, Gross FL, King JP, Flannery B, McLean HQ. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018. Vaccine. PMID 32145994 DOI: 10.1016/j.vaccine.2020.02.055  0.375
2020 Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, ... ... Flannery B, et al. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. Mmwr. Morbidity and Mortality Weekly Report. 69: 177-182. PMID 32078591 DOI: 10.15585/Mmwr.Mm6907A1  0.429
2020 Doyle JD, Beacham L, Martin ET, Talbot HK, Monto A, Gaglani M, Middleton DB, Silveira FP, Zimmerman RK, Alyanak E, Smith ER, Flannery BL, Rolfes M, Ferdinands JM. Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32067049 DOI: 10.1093/Cid/Ciaa160  0.38
2020 Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, ... ... Flannery B, et al. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32006430 DOI: 10.1093/Cid/Ciaa102  0.371
2020 Chung JR, Rolfes MA, Flannery B, Prasad P, O'Halloran A, Garg S, Fry AM, Singleton JA, Patel M, Reed C. Effects of Influenza Vaccination in the United States during the 2018-2019 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31905401 DOI: 10.1093/Cid/Ciz1244  0.404
2020 Flannery B, Fry AM. Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies. The Journal of Infectious Diseases. 220: 1237-1239. PMID 30561690 DOI: 10.1093/infdis/jiy717  0.373
2019 Florek K, Mutschler J, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15. Vaccine. PMID 31753674 DOI: 10.1016/j.vaccine.2019.10.060  0.399
2019 Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season. The Journal of Infectious Diseases. PMID 31665373 DOI: 10.1093/Infdis/Jiz543  0.408
2019 Foppa IM, Ferdinands JM, Chung J, Flannery B, Fry AM. Vaccination history as a confounder of studies of influenza vaccine effectiveness. Vaccine: X. 1: 100008. PMID 31384730 DOI: 10.1016/j.jvacx.2019.100008  0.384
2019 Hughes MM, Reed C, Flannery B, Garg S, Singleton JA, Fry AM, Rolfes MA. Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31344229 DOI: 10.1093/cid/ciz676  0.374
2019 Monto AS, Malosh RE, Evans R, Lauring AS, Gordon A, Thompson MG, Fry AM, Flannery B, Ohmit SE, Petrie JG, Martin ET. Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study. International Journal of Epidemiology. PMID 31038700 DOI: 10.1093/Ije/Dyz086  0.355
2019 Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Foust A, Sessions W, ... ... Flannery B, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. Mmwr. Morbidity and Mortality Weekly Report. 68: 135-139. PMID 30763298 DOI: 10.15585/Mmwr.Mm6806A2  0.439
2019 McLean HQ, King JP, Talley P, Flannery B, Spencer S, Levine MZ, Friedrich TC, Belongia EA. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016. Journal of the Pediatric Infectious Diseases Society. PMID 30759228 DOI: 10.1093/jpids/piz001  0.377
2019 Rolfes MA, Flannery B, Chung J, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman R, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, et al. Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30715278 DOI: 10.1093/Cid/Ciz075  0.405
2019 Chung JR, Flannery B, Ambrose CS, Bégué RE, Caspard H, DeMarcus L, Fowlkes AL, Kersellius G, Steffens A, Fry AM. Live Attenuated and Inactivated Influenza Vaccine Effectiveness. Pediatrics. PMID 30617239 DOI: 10.1542/peds.2018-2094  0.355
2018 Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine. PMID 30420119 DOI: 10.1016/j.vaccine.2018.10.093  0.369
2018 Appiah GD, Chung JR, Flannery B, Havers F, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM. Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16. Influenza and Other Respiratory Viruses. PMID 30408341 DOI: 10.1111/Irv.12616  0.386
2018 Havers FP, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, Fry AM, Flannery B. Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30371753 DOI: 10.1093/Cid/Ciy780  0.384
2018 Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM, et al. Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30204854 DOI: 10.1093/Cid/Ciy775  0.398
2018 Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, et al. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. Mmwr. Morbidity and Mortality Weekly Report. 67: 180-185. PMID 29447141 DOI: 10.1111/Ajt.14730  0.439
2018 Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, Burns E, Jernigan D, Olsen SJ, Bresee J, Reed C. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza and Other Respiratory Viruses. PMID 29446233 DOI: 10.1111/irv.12486  0.346
2018 King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. Vaccine. PMID 29395525 DOI: 10.1016/j.vaccine.2018.01.016  0.394
2018 Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, et al. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. The Journal of Infectious Diseases. PMID 29361005 DOI: 10.1093/Infdis/Jix634  0.379
2018 Rolfes MA, Gross FL, Flannery B, Meyers AFA, Luo M, Bastien N, Fowler RA, Katz JM, Levine MZ, Kumar A, Uyeki TM. Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011. The Journal of Infectious Diseases. PMID 29342251 DOI: 10.1093/Infdis/Jiy013  0.369
2017 Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine. PMID 29249545 DOI: 10.1016/j.vaccine.2017.12.014  0.403
2017 Florek NW, Campos LM, Braun KM, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children. Vaccine. PMID 29249543 DOI: 10.1016/j.vaccine.2017.12.024  0.371
2017 Dugan VG, Blanton L, Elal AIA, Alabi N, Barnes J, Brammer L, Burns E, Cummings CN, Davis T, Flannery B, Fry AM, Garg S, Garten R, Gubareva L, Jang Y, et al. Update: Influenza Activity - United States, October 1-November 25, 2017. Mmwr. Morbidity and Mortality Weekly Report. 66: 1318-1326. PMID 29216030 DOI: 10.15585/Mmwr.Mm6648A2  0.397
2017 Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson M, Monto AS, Martin ET, Belongia EA, McLean H, Fry AM, Havers F. Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29069334 DOI: 10.1093/Cid/Cix922  0.308
2017 Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. The New England Journal of Medicine. 377: 534-543. PMID 28792867 DOI: 10.1056/NEJMoa1700153  0.413
2017 Blanton L, Alabi N, Mustaquim D, Taylor C, Kniss K, Kramer N, Budd A, Garg S, Cummings CN, Chung J, Flannery B, Fry AM, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine. Mmwr. Morbidity and Mortality Weekly Report. 66: 668-676. PMID 28662019 DOI: 10.15585/Mmwr.Mm6625A3  0.327
2017 Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM. Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S. The Journal of Infectious Diseases. PMID 28633308 DOI: 10.1093/Infdis/Jix286  0.345
2017 Flannery B, Reynolds SB, Blanton L, Santibanez TA, O'Halloran A, Lu PJ, Chen J, Foppa IM, Gargiullo P, Bresee J, Singleton JA, Fry AM. Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014. Pediatrics. 139. PMID 28557757 DOI: 10.1542/peds.2016-4244  0.341
2017 Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, et al. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. Mmwr. Morbidity and Mortality Weekly Report. 66: 167-171. PMID 28207689 DOI: 10.15585/Mmwr.Mm6606A3  0.44
2016 Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28039340 DOI: 10.1093/cid/ciw816  0.396
2016 Shang M, Blanton L, Kniss K, Mustaquim D, Alabi N, Barnes S, Budd A, Davlin SL, Kramer N, Garg S, Cummings CN, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, et al. Update: Influenza Activity - United States, October 2-December 17, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 1439-1444. PMID 28033315 DOI: 10.15585/Mmwr.Mm655051A5  0.366
2016 Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27702768 DOI: 10.1093/Cid/Ciw635  0.388
2016 Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR. Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. Bmc Infectious Diseases. 16: 503. PMID 27659721 DOI: 10.1186/S12879-016-1839-X  0.314
2016 Budd A, Blanton L, Kniss K, Smith S, Mustaquim D, Davlin SL, Kramer N, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, Bresee J, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity - United States and Worldwide, May 22-September 10, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 1008-1014. PMID 27657671 DOI: 10.15585/mmwr.mm6537a5  0.355
2016 Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald C, Nowalk MP, Susick M, Moehling K, Spencer S, Chung JR, Flannery B, Zimmerman RK. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) viruses Among Children and Adolescents Following 2014-15 Inactivated and Live Attenuated Influenza Vaccination. Clinical and Vaccine Immunology : Cvi. PMID 27558294 DOI: 10.1128/CVI.00297-16  0.433
2016 Kim JH, Mishina M, Chung JR, Cole KS, Nowalk MP, Martin JM, Spencer S, Flannery B, Zimmerman RK, Sambhara S. Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season. The Journal of Infectious Diseases. PMID 27534687 DOI: 10.1093/infdis/jiw311  0.375
2016 Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM, Monto AS. Influenza Vaccine Effectiveness against Antigenically Drifted Influenza Higher than Expected in Hospitalized Adults: 2014-2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27369320 DOI: 10.1093/Cid/Ciw432  0.424
2016 Davlin SL, Blanton L, Kniss K, Mustaquim D, Smith S, Kramer N, Cohen J, Cummings CN, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, et al. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. Mmwr. Morbidity and Mortality Weekly Report. 65: 567-575. PMID 27281364 DOI: 10.15585/Mmwr.Mm6522A3  0.375
2016 Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. The Journal of Infectious Diseases. PMID 27190176 DOI: 10.1093/Infdis/Jiw181  0.335
2016 Foppa IM, Ferdinands JM, Chaves SS, Haber MJ, Reynolds SB, Flannery B, Fry AM. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. International Journal of Epidemiology. PMID 26979985 DOI: 10.1093/Ije/Dyw022  0.423
2016 Russell K, Blanton L, Kniss K, Mustaquim D, Smith S, Cohen J, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity - United States, October 4, 2015-February 6, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 146-53. PMID 26891596 DOI: 10.15585/mmwr.mm6506a3  0.357
2016 Fernandes EG, Leshem E, Patel M, Flannery B, Pellini AC, Veras MA, Sato HK. Hospital-based surveillance of intussusception among infants. Jornal De Pediatria. PMID 26804014 DOI: 10.1016/j.jped.2015.06.008  0.311
2016 Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, ... ... Flannery B, et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. The Journal of Infectious Diseases. PMID 26743842 DOI: 10.1093/Infdis/Jiv577  0.379
2016 Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, et al. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics. PMID 26738884 DOI: 10.1542/Peds.2015-3279  0.407
2015 Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ, Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belongia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM. Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 months to 8 Years Old during 2011-2012 and 2012-2013: The Importance of Two Priming Doses. The Pediatric Infectious Disease Journal. PMID 26658375 DOI: 10.1097/Inf.0000000000001006  0.363
2015 Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, Gaglani M, Jackson ML, King JP, Nowalk MP, Benoit J, Robertson A, Thaker SN, Monto AS, Ohmit SE. Illness Severity and Work Productivity Loss among Working Adults with Medically-Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26565004 DOI: 10.1093/Cid/Civ952  0.386
2015 Blanton L, Kniss K, Smith S, Mustaquim D, Steffens C, Flannery B, Fry AM, Bresee J, Wallis T, Garten R, Xu X, Elal AI, Gubareva L, Wentworth DE, Burns E, et al. Update: Influenza Activity - United States and Worldwide, May 24-September 5, 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 1011-6. PMID 26390411 DOI: 10.15585/mmwr.mm6436a4  0.357
2015 Jackson ML, Jackson LA, Kieke B, McClure D, Gaglani M, Murthy K, Malosh R, Monto A, Zimmerman RK, Foppa IM, Flannery B, Thompson MG. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. 33: 5181-7. PMID 26271827 DOI: 10.1016/J.Vaccine.2015.07.098  0.411
2015 Suarez-Castaneda E, Burnett E, Elas M, Baltrons R, Pezzoli L, Flannery B, Kleinbaum D, Oliveira LH, Danovaro-Holliday MC. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador. Vaccine. PMID 26263200 DOI: 10.1016/J.Vaccine.2015.07.092  0.332
2015 Cardoso CW, Ribeiro GS, Reis MG, Flannery B, Reis JN. Effectiveness of meningococcal C conjugate vaccine in salvador, Brazil: a case-control study. Plos One. 10: e0123734. PMID 25874777 DOI: 10.1371/journal.pone.0123734  0.318
2015 Havers F, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Eng HF, Lamerato L, Campbell AP, et al. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1677-80. PMID 25722198 DOI: 10.1093/Cid/Civ146  0.342
2015 Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 10-5. PMID 25590680  0.438
2014 Reed C, Kim IK, Singleton JA, Chaves SS, Flannery B, Finelli L, Fry A, Burns E, Gargiullo P, Jernigan D, Cox N, Bresee J. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. Mmwr. Morbidity and Mortality Weekly Report. 63: 1151-4. PMID 25503917  0.422
2014 Domingues CM, de Fátima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program. The Journal of Infectious Diseases. S143-51. PMID 25316829 DOI: 10.1093/infdis/jit588  0.315
2014 Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, Nowalk MP, Moehling KK, Flannery B, Thompson MG, Fry AM. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 774-82. PMID 25034419 DOI: 10.1093/Cid/Ciu422  0.357
2014 Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil. Vaccine. 32: 3402-8. PMID 24736002 DOI: 10.1016/j.vaccine.2014.04.015  0.306
2014 Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Berman L, Foust A, Sessions W, et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. Mmwr. Morbidity and Mortality Weekly Report. 63: 137-42. PMID 24553196  0.447
2013 Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine. The Journal of Pediatrics. 163: S12-8. PMID 23773588 DOI: 10.1016/j.jpeds.2013.03.025  0.362
2012 Cardoso CW, Pinto LL, Reis MG, Flannery B, Reis JN. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil. Vaccine. 30: 5541-6. PMID 22749604 DOI: 10.1016/j.vaccine.2012.06.044  0.307
2012 Vieira JC, Carvalho MT, Checchia RL, Trombiere M, Flannery B. Survey of rubella knowledge and acceptability of rubella vaccination among Brazilian adults prior to mass vaccination. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 30: 335-41. PMID 22124692  0.301
2012 von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis Md, Madhi SA, Klugman KP. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine. 30: 565-71. PMID 22119925 DOI: 10.1016/J.Vaccine.2011.11.066  0.309
2011 Segatto C, Samad S, Mengue SS, Rodrigues G, Flannery B, Toscano CM. Historical analysis of birth cohorts not vaccinated against rubella prior to national rubella vaccination campaign, Brazil. The Journal of Infectious Diseases. S608-15. PMID 21954255 DOI: 10.1093/infdis/jir357  0.317
2011 Zanella RC, Bokermann S, Andrade AL, Flannery B, Brandileone MC. Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil. Vaccine. 29: 8937-42. PMID 21945960 DOI: 10.1016/j.vaccine.2011.09.053  0.33
2011 Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. The New England Journal of Medicine. 364: 2283-92. PMID 21675888 DOI: 10.1056/NEJMoa1012952  0.313
2011 de Carvalho CX, Kipnis A, Thörn L, de Andrade JG, Pimenta F, Brandileone MC, Zanella RC, Flannery B, Sgambatti S, Andrade AL. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination. Vaccine. 29: 1438-42. PMID 21199703 DOI: 10.1016/j.vaccine.2010.12.045  0.341
2009 Lee EH, Corcino M, Moore A, Garib Z, Peña C, Sánchez J, Fernández J, Feris-Iglesias JM, Flannery B. Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 24: 161-8. PMID 19115543 DOI: 10.1590/s1020-49892008000900002  0.358
2008 Lee EH, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, Braka F, Flannery B, Zuber PL, Feikin DR. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Tropical Medicine & International Health : Tm & Ih. 13: 495-502. PMID 18312475 DOI: 10.1111/j.1365-3156.2008.02027.x  0.328
2007 Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. The Journal of Infectious Diseases. 196: 1346-54. PMID 17922399 DOI: 10.1086/521626  0.31
2002 Sarkar U, Nascimento SF, Barbosa R, Martins R, Nuevo H, Kalofonos I, Kalafanos I, Grunstein I, Flannery B, Dias J, Riley LW, Reis MG, Ko AI. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. The American Journal of Tropical Medicine and Hygiene. 66: 605-10. PMID 12201599 DOI: 10.4269/Ajtmh.2002.66.605  0.453
2001 Flannery B, Pereira MM, De Freitas Velloso PL, De Castro Carvalho C, De Codes LG, De Saboia Orrico G, Ribeiro Dourado CM, Riley LW, Reis MG, Ko AI. Referral pattern of Leptospirosis cases during a large urban epidemic of dengue American Journal of Tropical Medicine and Hygiene. 65: 657-663. PMID 11716133 DOI: 10.4269/Ajtmh.2001.65.657  0.507
2001 Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, Da Silva ED, Ferreira AG, Riley LW, Reis MG, Haake DA, Ko AI. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. Journal of Clinical Microbiology. 39: 3303-10. PMID 11526167 DOI: 10.1128/Jcm.39.9.3303-3310.2001  0.513
2001 Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, Reis MG, Levett PN, Ko AI, Haake DA. Leptospiral Proteins Recognized during the Humoral Immune Response to Leptospirosis in Humans Infection and Immunity. 69: 4958-4968. PMID 11447174 DOI: 10.1128/Iai.69.8.4958-4968.2001  0.329
Show low-probability matches.